OTC Pharmaceuticals: Global Industry Guide

Home >
Life Sciences >
Pharmaceutical >
OTC Pharmaceuticals: Global Industry Guide

Report price : $ 1 495
Publication date : February 2008
Length : 355 pages

Datamonitor's OTC Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the OTC pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).

* Includes a five-year forecast of the industry

Highlights

The global OTC pharmaceuticals market grew by 4% in 2007 to reach a value of $84.8 billion.

In 2012, the global OTC pharmaceuticals market is forecast to have a value of $101.8 billion, an increase of 20.1% since 2007.

Cough and cold preparations form the most lucrative sector of the global market, with an 18.4% share of the market by value.

The Asia-Pacific is the leading region in the global market, with a 38.8% share of the total market value.

Pfizer Inc. is the leading company in the global market, with a 6.3% share of the market by value.

Pharmacies and drugstores form the most lucrative distribution channel, with a 67.2% share of the global market by value.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.

TABLE OF CONTENTS
List of Figures 25
CHAPTER 1 INTRODUCTION 36
1.1 What is this report about? 36
1.2 Who is the target reader? 36
1.3 How to use this report 36
1.4 Definitions 37
CHAPTER 2 Global OTC Pharmaceuticals 38
2.1 Market Overview 38
Research Highlights 38
Market Analysis 38
2.2 Market Value 39
2.3 Market Segmentation I 40
2.4 Market Segmentation II 41
2.5 Market Share 42
2.6 Five Forces Analysis 43
Summary 43
Buyer Power 44
Supplier Power 45
New Entrants 46
Substitutes 47
Rivalry 48
2.7 Leading Companies 49
Pfizer Inc 49
GlaxoSmithKline Plc 51
Novartis AG 54
2.8 Distribution 57
2.9 Market Forecasts 58
Market Value Forecast 58
CHAPTER 3 OTC Pharmaceuticals in Asia-Pacific 59
3.1 Market Overview 59
Research Highlights 59
Market Analysis 59
3.2 Market Value 60
3.3 Market Segmentation I 61
3.4 Market Segmentation II 62
3.5 Market Share 63
3.6 FIVE FORCES ANALYSIS 64
Summary 64
Buyer Power 65
Supplier Power 66
New Entrants 67
Substitutes 68
Rivalry 69
3.7 Leading Companies 70
Nin Jiom 70
Pfizer Inc 70
Novartis AG 72
3.8 Distribution 75
3.9 Market Forecasts 76
Market Value Forecast 76
CHAPTER 4 OTC Pharmaceuticals in Europe 77
4.1 Market Overview 77
Research Highlights 77
Market Analysis 77
4.2 Market Value 78
4.3 Market Segmentation I 79
4.4 Market Segmentation II 80
4.5 Market Share 81
4.6 Five Forces Analysis 82
Summary 82
Buyer Power 83
Supplier Power 84
New Entrants 85
Substitutes 86
Rivalry 87
4.7 Leading Companies 88
Bayer AG 88
Pfizer Inc 91
GlaxoSmithKline Plc 93
4.8 Distribution 96
4.9 Market Forecasts 97
Market Value Forecast 97
4.10 Macroeconomic Indicators 98
CHAPTER 5 OTC Pharmaceuticals in Belgium 99
5.1 Market Overview 99
Research Highlights 99
Market Analysis 99
5.2 Market Value 100
5.3 Market Segmentation I 101
5.4 Market Segmentation II 102
5.5 Market Share 103
5.6 FIVE FORCES ANALYSIS 104
Summary 104
Buyer Power 105
Supplier Power 106
New Entrants 107
Substitutes 108
Rivalry 109
5.7 Leading Companies 110
Pfizer Inc 110
Novartis AG 113
Omega Pharma NV 116
5.8 Distribution 119
5.9 Market Forecasts 120
Market Value Forecast 120
5.10 Macroeconomic Indicators 121
CHAPTER 6 OTC Pharmaceuticals in Canada 123
6.1 Market Overview 123
Research Highlights 123
Market Analysis 123
6.2 Market Value 124
6.3 Market Segmentation I 125
6.4 Market Segmentation II 126
6.5 Market Share 127
6.6 FIVE FORCES ANALYSIS 128
Summary 128
Buyer Power 129
Supplier Power 130
New Entrants 131
Substitutes 132
Rivalry 133
6.7 Leading Companies 134
Pfizer Inc 134
GlaxoSmithKline Plc 137
Jamieson Laboratories 141
6.8 Distribution 142
6.9 Market Forecasts 143
Market Value Forecast 143
6.10 Macroeconomic Indicators 144
CHAPTER 7 OTC Pharmaceuticals in China 146
7.1 Market Overview 146
Research Highlights 146
Market Analysis 146
7.2 Market Value 147
7.3 Market Segmentation I 148
7.4 Market Segmentation II 149
7.5 Market Share 150
7.6 FIVE FORCES ANALYSIS 151
Summary 151
Buyer Power 152
Supplier Power 153
New Entrants 154
Substitutes 155
Rivalry 156
7.7 Leading Companies 157
Johnson & Johnson 157
7.8 Distribution 160
7.9 Market Forecasts 161
Market Value Forecast 161
7.10 Macroeconomic Indicators 162
CHAPTER 8 OTC Pharmaceuticals in France 164
8.1 Market Overview 164
Research Highlights 164
Market Analysis 164
8.2 Market Value 165
8.3 Market Segmentation I 166
8.4 Market Segmentation II 167
8.5 Market Share 168
8.6 Five Forces Analysis 169
Summary 169
Buyer Power 170
Supplier Power 171
New Entrants 172
Substitutes 173
Rivalry 174
8.7 Leading Companies 175
Procter & Gamble Company, The 175
Sanofi-Aventis 178
Pfizer Inc 180
8.8 Distribution 182
8.9 Market Forecasts 183
Market Value Forecast 183
8.10 Macroeconomic Indicators 184
CHAPTER 9 OTC Pharmaceuticals in Germany 186
9.1 Market Overview 186
Research Highlights 186
Market Analysis 186
9.2 Market Value 187
9.3 Market Segmentation I 188
9.4 Market Segmentation II 189
9.5 Market Share 190
9.6 Five Forces Analysis 191
Summary 191
Buyer Power 192
Supplier Power 193
New Entrants 194
Substitutes 195
Rivalry 196
9.7 Leading Companies 197
Bayer AG 197
Pfizer Inc 200
GlaxoSmithKline Plc 202
9.8 Distribution 206
9.9 Market Forecasts 207
Market Value Forecast 207
9.10 Macroeconomic Indicators 208
CHAPTER 10 OTC Pharmaceuticals in Italy 210
10.1 Market Overview 210
Research Highlights 210
Market Analysis 210
10.2 Market Value 211
10.3 Market Segmentation I 212
10.4 Market Segmentation II 213
10.5 Market Share 214
10.6 FIVE FORCES ANALYSIS 215
Summary 215
Buyer Power 216
Supplier Power 217
New Entrants 218
Substitutes 219
Rivalry 220
10.7 Leading Companies 221
Boehringer Ingelheim GmbH 221
Bayer AG 224
GlaxoSmithKline Plc 227
10.8 Distribution 231
10.9 Market Forecasts 232
Market Value Forecast 232
10.10 Macroeconomic Indicators 233
CHAPTER 11 OTC Pharmaceuticals in Japan 235
11.1 Market Overview 235
Research Highlights 235
Market Analysis 235
11.2 Market Value 236
11.3 Market Segmentation I 237
11.4 Market Segmentation II 238
11.5 Market Share 239
11.6 Five Forces Analysis 240
Summary 240
Buyer Power 241
Supplier Power 242
New Entrants 243
Substitutes 244
Rivalry 245
11.7 Leading Companies 246
Pfizer Inc 246
Novartis AG 249
Wyeth 252
11.8 Distribution 255
11.9 Market Forecasts 256
Market Value Forecast 256
11.10 Macroeconomic Indicators 257
CHAPTER 12 OTC Pharmaceuticals in the Netherlands 258
12.1 Market Overview 258
Research Highlights 258
Market Analysis 258
12.2 Market Value 259
12.3 Market Segmentation I 260
12.4 Market Segmentation II 261
12.5 Market Share 262
12.6 FIVE FORCES ANALYSIS 263
Summary 263
Buyer Power 264
Supplier Power 265
New Entrants 266
Substitutes 267
Rivalry 268
12.7 Leading Companies 269
Bayer AG 269
Pfizer Inc 272
Procter & Gamble Company, The 274
12.8 Distribution 277
12.9 Market Forecasts 278
Market Value Forecast 278
12.10 Macroeconomic Indicators 279
CHAPTER 13 OTC Pharmaceuticals in Spain 281
13.1 Market Overview 281
Research Highlights 281
Market Analysis 281
13.2 Market Value 282
13.3 Market Segmentation I 283
13.4 Market Segmentation II 284
13.5 Market Share 285
13.6 FIVE FORCES ANALYSIS 286
Summary 286
Buyer Power 287
Supplier Power 288
New Entrants 289
Substitutes 290
Rivalry 291
13.7 Leading Companies 292
Pfizer Inc 292
GlaxoSmithKline Plc 295
Sanofi-Aventis 299
13.8 Distribution 301
13.9 Market Forecasts 302
Market Value Forecast 302
13.10 Macroeconomic Indicators 303
CHAPTER 14 OTC Pharmaceuticals in the United Kingdom 305
14.1 Market Overview 305
Research Highlights 305
Market Analysis 305
14.2 Market Value 306
14.3 Market Segmentation I 307
14.4 Market Segmentation II 308
14.5 Market Share 309
14.6 Five Forces Analysis 310
Summary 310
Buyer Power 311
Supplier Power 312
New Entrants 313
Substitutes 314
Rivalry 315
14.7 Leading Companies 316
Pfizer Inc 316
GlaxoSmithKline Plc 319
Reckitt Benckiser PLC 323
Key Metrics 325
14.8 Distribution 326
14.9 Market Forecasts 327
Market Value Forecast 327
14.10 Macroeconomic Indicators 328
CHAPTER 15 OTC Pharmaceuticals in the United States 330
15.1 Market Overview 330
Research Highlights 330
Market Analysis 330
15.2 Market Value 331
15.3 Market Segmentation I 332
15.4 Market Segmentation II 333
15.5 Market Share 334
15.6 Five Forces Analysis 335
Summary 335
Buyer Power 336
Supplier Power 337
New Entrants 338
Substitutes 339
Rivalry 340
15.7 Leading Companies 341
Wyeth 341
Pfizer Inc 344
GlaxoSmithKline Plc 347
15.8 Distribution 351
15.9 Market Forecasts 352
Market Value Forecast 352
15.10 Macroeconomic Indicators 353
CHAPTER 16 Appendix 354
16.1 Methodology 354
16.2 Industry Associations 355
16.3 Related Datamonitor Research 355

LIST OF TABLES
Table 1: Global OTC Pharmaceuticals Market Value: $ billion, 2003-2007 39
Table 2: Global OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 40
Table 3: Global OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 41
Table 4: Global OTC Pharmaceuticals Market Share: % Share, by Value, 2007 42
Table 5: Key Facts: Pfizer Inc 49
Table 6: Key Financials: Pfizer Inc 50
Table 7: Key Facts: GlaxoSmithKline Plc 51
Table 8: Key Financials: GlaxoSmithKline Plc 53
Table 9: Key Facts: Novartis AG 54
Table 10: Key Financials: Novartis AG 56
Table 11: Global OTC Pharmaceuticals Distribution: % Share, by Value, 2007 57
Table 12: Global OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012 58
Table 13: Asia-Pacific OTC Pharmaceuticals Market Value: $ billion, 2003-2007 60
Table 14: Asia-Pacific OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 61
Table 15: Asia-Pacific OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 62
Table 16: Asia-Pacific OTC Pharmaceuticals Market Share: % Share, by Value, 2007 63
Table 17: Key Facts: Nin Jiom 70
Table 18: Key Facts: Pfizer Inc 70
Table 19: Key Financials: Pfizer Inc 72
Table 20: Key Facts: Novartis AG 72
Table 21: Key Financials: Novartis AG 74
Table 22: Asia-Pacific OTC Pharmaceuticals Distribution: % Share, by Value, 2007 75
Table 23: Asia-Pacific OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012 76
Table 24: Europe OTC Pharmaceuticals Market Value: $ billion, 2003-2007 78
Table 25: Europe OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 79
Table 26: Europe OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 80
Table 27: Europe OTC Pharmaceuticals Market Share: % Share, by Value, 2007 81
Table 28: Key Facts: Bayer AG 88
Table 29: Key Financials: Bayer AG 90
Table 30: Key Facts: Pfizer Inc 91
Table 31: Key Financials: Pfizer Inc 92
Table 32: Key Facts: GlaxoSmithKline Plc 93
Table 33: Key Financials: GlaxoSmithKline Plc 95
Table 34: Europe OTC Pharmaceuticals Distribution: % Share, by Value, 2007 96
Table 35: Europe OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012 97
Table 36: Europe Exchange Rate, 2003 98
Table 37: Belgium OTC Pharmaceuticals Market Value: $ million, 2003-2007 100
Table 38: Belgium OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 101
Table 39: Belgium OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 102
Table 40: Belgium OTC Pharmaceuticals Market Share: % Share, by Value, 2007 103
Table 41: Key Facts: Pfizer Inc 110
Table 42: Key Financials: Pfizer Inc 112
Table 43: Key Facts: Novartis AG 113
Table 44: Key Financials: Novartis AG 115
Table 45: Key Facts: Omega Pharma NV 116
Table 46: Key Financials: Omega Pharma NV 118
Table 47: Belgium OTC Pharmaceuticals Distribution: % Share, by Value, 2007 119
Table 48: Belgium OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012 120
Table 49: Belgium Size of Population (million) , 2003-2007 121
Table 50: Belgium GDP (Constant 2000 Prices, $ billion), 2003-2007 121
Table 51: Belgium Inflation, 2003-2007 121
Table 52: Belgium Exchange Rate, 2003 122
Table 53: Canada OTC Pharmaceuticals Market Value: $ million, 2003-2007 124
Table 54: Canada OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 125
Table 55: Canada OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 126
Table 56: Canada OTC Pharmaceuticals Market Share: % Share, by Value, 2007 127
Table 57: Key Facts: Pfizer Inc 134
Table 58: Key Financials: Pfizer Inc 136
Table 59: Key Facts: GlaxoSmithKline Plc 137
Table 60: Key Financials: GlaxoSmithKline Plc 140
Table 61: Key Facts: Jamieson Laboratories 141
Table 62: Canada OTC Pharmaceuticals Distribution: % Share, by Value, 2007 142
Table 63: Canada OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012 143
Table 64: Canada Size of Population (million) , 2003-2007 144
Table 65: Canada GDP (Constant 2000 Prices, $ billion), 2003-2007 144
Table 66: Canada Inflation, 2003-2007 144
Table 67: Canada Exchange Rate, 2003 145
Table 68: China OTC Pharmaceuticals Market Value: $ billion, 2003-2007 147
Table 69: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 148
Table 70: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 149
Table 71: China OTC Pharmaceuticals Market Share: % Share, by Value, 2007 150
Table 72: Key Facts: Johnson & Johnson 157
Table 73: Key Financials: Johnson & Johnson 159
Table 74: China OTC Pharmaceuticals Distribution: % Share, by Value, 2007 160
Table 75: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012 161
Table 76: China Size of Population (million) , 2003-2007 162
Table 77: China GDP (Constant 2000 Prices, $ billion), 2003-2007 162
Table 78: China Inflation, 2003-2007 162
Table 79: China Exchange Rate, 2003 163
Table 80: France OTC Pharmaceuticals Market Value: $ million, 2003-2007 165
Table 81: France OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 166
Table 82: France OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 167
Table 83: France OTC Pharmaceuticals Market Share: % Share, by Value, 2007 168
Table 84: Key Facts: Procter & Gamble Company, The 175
Table 85: Key Financials: Procter & Gamble Company, The 177
Table 86: Key Facts: Sanofi-Aventis 178
Table 87: Key Financials: Sanofi-Aventis 179
Table 88: Key Facts: Pfizer Inc 180
Table 89: Key Financials: Pfizer Inc 181
Table 90: France OTC Pharmaceuticals Distribution: % Share, by Value, 2007 182
Table 91: France OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012 183
Table 92: France Size of Population (million) , 2003-2007 184
Table 93: France GDP (Constant 2000 Prices, $ billion), 2003-2007 184
Table 94: France Inflation, 2003-2007 184
Table 95: France Exchange Rate, 2003 185
Table 96: Germany OTC Pharmaceuticals Market Value: $ billion, 2003-2007 187
Table 97: Germany OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 188
Table 98: Germany OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 189
Table 99: Germany OTC Pharmaceuticals Market Share: % Share, by Value, 2007 190
Table 100: Key Facts: Bayer AG 197
Table 101: Key Financials: Bayer AG 199
Table 102: Key Facts: Pfizer Inc 200
Table 103: Key Financials: Pfizer Inc 201
Table 104: Key Facts: GlaxoSmithKline Plc 202
Table 105: Key Financials: GlaxoSmithKline Plc 205
Table 106: Germany OTC Pharmaceuticals Distribution: % Share, by Value, 2007 206
Table 107: Germany OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012 207
Table 108: Germany Size of Population (million) , 2003-2007 208
Table 109: Germany GDP (Constant 2000 Prices, $ billion), 2003-2007 208
Table 110: Germany Inflation, 2003-2007 208
Table 111: Germany Exchange Rate, 2003 209
Table 112: Italy OTC Pharmaceuticals Market Value: $ million, 2003-2007 211
Table 113: Italy OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 212
Table 114: Italy OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 213
Table 115: Italy OTC Pharmaceuticals Market Share: % Share, by Value, 2007 214
Table 116: Key Facts: Boehringer Ingelheim GmbH 221
Table 117: Key Financials: Boehringer Ingelheim GmbH 223
Table 118: Key Facts: Bayer AG 224
Table 119: Key Financials: Bayer AG 226
Table 120: Key Facts: GlaxoSmithKline Plc 227
Table 121: Key Financials: GlaxoSmithKline Plc 230
Table 122: Italy OTC Pharmaceuticals Distribution: % Share, by Value, 2007 231
Table 123: Italy OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012 232
Table 124: Italy Size of Population (million) , 2003-2007 233
Table 125: Italy GDP (Constant 2000 Prices, $ billion), 2003-2007 233
Table 126: Italy Inflation, 2003-2007 233
Table 127: Italy Exchange Rate, 2003 234
Table 128: Japan OTC Pharmaceuticals Market Value: $ billion, 2003-2007 236
Table 129: Japan OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 237
Table 130: Japan OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 238
Table 131: Japan OTC Pharmaceuticals Market Share: % Share, by Value, 2007 239
Table 132: Key Facts: Pfizer Inc 246
Table 133: Key Financials: Pfizer Inc 248
Table 134: Key Facts: Novartis AG 249
Table 135: Key Financials: Novartis AG 250
Table 136: Key Facts: Wyeth 252
Table 137: Key Financials: Wyeth 254
Table 138: Japan OTC Pharmaceuticals Distribution: % Share, by Value, 2007 255
Table 139: Japan OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012 256
Table 140: Japan Size of Population (million) , 2003-2007 257
Table 141: Japan GDP (Constant 2000 Prices, $ billion), 2003-2007 257
Table 142: Japan Exchange Rate, 2003 257
Table 143: Netherlands OTC Pharmaceuticals Market Value: $ million, 2003-2007 259
Table 144: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 260
Table 145: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 261
Table 146: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2007 262
Table 147: Key Facts: Bayer AG 269
Table 148: Key Financials: Bayer AG 271
Table 149: Key Facts: Pfizer Inc 272
Table 150: Key Financials: Pfizer Inc 273
Table 151: Key Facts: Procter & Gamble Company, The 274
Table 152: Key Financials: Procter & Gamble Company, The 276
Table 153: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2007 277
Table 154: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012 278
Table 155: Netherlands Size of Population (million) , 2003-2007 279
Table 156: Netherlands GDP (Constant 2000 Prices, $ billion), 2003-2007 279
Table 157: Netherlands Inflation, 2003-2007 279
Table 158: Netherlands Exchange Rate, 2003 280
Table 159: Spain OTC Pharmaceuticals Market Value: $ million, 2003-2007 282
Table 160: Spain OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 283
Table 161: Spain OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 284
Table 162: Spain OTC Pharmaceuticals Market Share: % Share, by Value, 2007 285
Table 163: Key Facts: Pfizer Inc 292
Table 164: Key Financials: Pfizer Inc 294
Table 165: Key Facts: GlaxoSmithKline Plc 295
Table 166: Key Financials: GlaxoSmithKline Plc 298
Table 167: Key Facts: Sanofi-Aventis 299
Table 168: Key Financials: Sanofi-Aventis 300
Table 169: Spain OTC Pharmaceuticals Distribution: % Share, by Value, 2007 301
Table 170: Spain OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012 302
Table 171: Spain Size of Population (million) , 2003-2007 303
Table 172: Spain GDP (Constant 2000 Prices, $ billion), 2003-2007 303
Table 173: Spain Inflation, 2003-2007 303
Table 174: Spain Exchange Rate, 2003 304
Table 175: United Kingdom OTC Pharmaceuticals Market Value: $ billion, 2003-2007 306
Table 176: United Kingdom OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 307
Table 177: United Kingdom OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 308
Table 178: United Kingdom OTC Pharmaceuticals Market Share: % Share, by Value, 2007 309
Table 179: Key Facts: Pfizer Inc 316
Table 180: Key Financials: Pfizer Inc 318
Table 181: Key Facts: GlaxoSmithKline Plc 319
Table 182: Key Financials: GlaxoSmithKline Plc 322
Table 183: Key Facts: Reckitt Benckiser PLC 323
Table 184: Key Financials: Reckitt Benckiser PLC 325
Table 185: United Kingdom OTC Pharmaceuticals Distribution: % Share, by Value, 2007 326
Table 186: United Kingdom OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012 327
Table 187: United Kingdom Size of Population (million) , 2003-2007 328
Table 188: United Kingdom GDP (Constant 2000 Prices, $ billion), 2003-2007 328
Table 189: United Kingdom Inflation, 2003-2007 328
Table 190: United Kingdom Exchange Rate, 2003 329
Table 191: United States OTC Pharmaceuticals Market Value: $ billion, 2003-2007 331
Table 192: United States OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 332
Table 193: United States OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 333
Table 194: United States OTC Pharmaceuticals Market Share: % Share, by Value, 2007 334
Table 195: Key Facts: Wyeth 341
Table 196: Key Financials: Wyeth 342
Table 197: Key Facts: Pfizer Inc 344
Table 198: Key Financials: Pfizer Inc 346
Table 199: Key Facts: GlaxoSmithKline Plc 347
Table 200: Key Financials: GlaxoSmithKline Plc 350
Table 201: United States OTC Pharmaceuticals Distribution: % Share, by Value, 2007 351
Table 202: United States OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012 352
Table 203: United States Size of Population (million) , 2003-2007 353
Table 204: United States GDP (Constant 2000 Prices, $ billion), 2003-2007 353
Table 205: United States Inflation, 2003-2007 353

RELATED REPORTS

Emerging pharmaceutical markets Argentina and Mexico

$ 7 600
March 2008
106 pages

IntroductionLatin American countries have attracted a lot of attention recently. With their economies currently stable, their geographic location and low-cost is ideal for investors. In addition, having such a high and varied population eases recruitment for clinical trials, and the demographics sho ...

Industries : Pharmaceutical | Countries : Mexico, Argentina, Canada, USA, Croatia

Pharmaceuticals: Global Industry Guide

$ 1 495
February 2008
243 pages

Datamonitor's Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading co ...

Industries : Pharmaceutical | Countries : Mexico, Brazil, Canada, USA, China, Japan, Taiwan, India, Singapore, Russia, Hungary, Poland, Czech Republic, Denmark, Norway, Sweden, Germany, Belgium, Spain, France, Italy, Netherlands, United Kingdom, Australia

Stakeholder Opinions: Systemic Lupus Erythematosus - Market set to enter era of biologic therapies

$ 3 800
March 2008
108 pages

IntroductionSLE is a chronic, life-long and potentially fatal autoimmune disease characterized by multiple system distress and unpredictable flares. Therapy is largely off-label and a huge demand exists for new SLE therapies because of the potential for serious side effects from drugs currently used ...

Industries : Pharmaceutical | Countries : Mexico, Canada, USA, China, Japan, India, Croatia, Germany, Spain, France, Italy, United Kingdom

Insulin Delivery Systems Market Analysis (2007-2010)

$ 1 400
January 2008
250 pages

The research report “Insulin Delivery Systems Market Analysis (2007-2010)” by RNCOS gives an exhaustive analysis on the global insulin market and various Insulin delivery methods. The report investigates the market for various devices used for delivering insulin, including syringes, pens, pumps, ...

Industries : Medical Devices, Pharmaceutical | Countries : Egypt, Mexico, Brazil, USA, China, Japan, India, Pakistan, Russia, Germany

Emerging Pharmaceutical Markets Globally

$ 1 800
January 2008
250 pages

The report ``Emerging Pharmaceutical Markets Globally`` provides an exhaustive overview of the pharmaceutical markets in the E7 countries (Brazil, Russia, India, China, Mexico, Turkey and Indonesia). This Report provides a detailed account of the factors that are redefining the structure and composi ...

Industries : Pharmaceutical | Countries : Mexico, Brazil, China, India, Indonesia, Russia, Turkey

Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses - Provides analysis of recent events in the osteoarthritis disease area and their impact on the market. Includes an event-based, indication-specific ten year forecast of both pipeline and mar

$ 15 200
May 2008
71 pages

IntroductionWith several recent non-approvable decisions in the osteoarthritis market since 2006, Datamonitor has updated its forecast to account for the effect on the market. We have revised the market outlook over the next 10 years using the latest IMS data. We expect the market to grow steadily, ...

Industries : Pharmaceutical | Countries : Mexico, Brazil, Canada, USA, Japan, Croatia, Germany, Spain, France, Italy, United Kingdom, Australia

OTC Pharmaceuticals: Global Industry Guide - get our PDF brochure

24/7 Customer Service

Contact Clare now !

(866) 682 9815
Ask Clare by email

Related industries

Pharmaceutical Industry
- in Mexico
- in Brazil
- in Canada
- in USA
- in China

Related countries

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.